A, A., S, R., BI, R., & A, S. (2020). NODE. Health Meeting Report and Panel Discussion - The FDA's Changing Regulatory Landscape for Digital Health Technologies and Digital Health Innovation during COVID-19: A Discussion with Eric Topol and Bakul Patel, Moderated by Aenor Sawyer. Digital biomarkers, 4(3), 128. https://doi.org/10.1159/000512681
Chicago Style (17th ed.) CitationA, Andoni, Ramedani S, Rosner BI, and Sawyer A. "NODE. Health Meeting Report and Panel Discussion - The FDA's Changing Regulatory Landscape for Digital Health Technologies and Digital Health Innovation During COVID-19: A Discussion with Eric Topol and Bakul Patel, Moderated by Aenor Sawyer." Digital Biomarkers 4, no. 3 (2020): 128. https://doi.org/10.1159/000512681.
MLA (9th ed.) CitationA, Andoni, et al. "NODE. Health Meeting Report and Panel Discussion - The FDA's Changing Regulatory Landscape for Digital Health Technologies and Digital Health Innovation During COVID-19: A Discussion with Eric Topol and Bakul Patel, Moderated by Aenor Sawyer." Digital Biomarkers, vol. 4, no. 3, 2020, p. 128, https://doi.org/10.1159/000512681.